INTRODUCTION
============

Since the "one gene-one enzyme hypothesis" ([@b5-molce-39-5-367]) and the "one gene-one polypeptide hypothesis" ([@b24-molce-39-5-367]) were proposed, the perception among geneticists and molecular biologists earlier on was that proteins were the only core molecules that controlled diverse cellular processes and gene expression regulation, and that RNAs were passive carriers of genetic information ([@b13-molce-39-5-367]). However, this hypothesis was challenged by polypeptides arising from alternative splicing. In the 1980s, Thomas Cech's group first demonstrated that the role of RNA molecules extended beyond that, to enzymatic regulation ([@b7-molce-39-5-367]; [@b32-molce-39-5-367]).

The idea of RNA as a primordial molecule was brewing in the 1960s. Subsequently, the "RNA world" hypothesis was proposed, according to which the earliest forms of genetic information and effector molecules were RNAs. This hypothesis has been supported by the observation of self-cleavage of viral RNAs with a structural model of the active sites ([@b14-molce-39-5-367]) and additional enzymatic activities such as RNA-catalyzed RNA polymerization ([@b29-molce-39-5-367]) and peptide bond formation ([@b59-molce-39-5-367]). However, it was still believed that such transcriptional and translational roles of RNAs were later taken over by DNA and protein, respectively, and that RNA had no such regulatory roles in genomes.

Eventually, the protein- and DNA-centric view was challenged by the discovery of a small regulatory noncoding RNA (ncRNA) group, which included microRNAs (miRNAs) ([@b36-molce-39-5-367]; [@b47-molce-39-5-367]; [@b57-molce-39-5-367]) and the steroid receptor RNA activator (SRA; a ncRNA with both coding and noncoding function) ([@b11-molce-39-5-367]; [@b34-molce-39-5-367]), which was considered a bifunctional RNA. miRNA downregulates hundreds of conserved mRNA targets by base-pairing to the 3′-untranslated region (UTR) of the target in a posttranscriptional and translational manner ([@b4-molce-39-5-367]). Thousands of miRNAs participate in modulating diverse biological processes by controlling the expression level of more than 50% of protein-coding genes ([@b4-molce-39-5-367]). The first mammalian bifunctional RNA discovered, SRA, mediates the transactivation of eukaryotic gene expression as an RNA ([@b34-molce-39-5-367]) and encodes a highly conserved SRA protein in breast cancer cells ([@b11-molce-39-5-367]). The SRA protein Np95 mediates epigenetic upregulation of gene expression by recruiting Dnmt1 to methylated DNA ([@b50-molce-39-5-367]). In turn, *VegT* and *Oskar* have been classified as bifunctional RNA with coding and noncoding functions in animal development ([@b26-molce-39-5-367]; [@b31-molce-39-5-367]).

During the last decade, reproducible transcription across mammalian coding and noncoding genomes were extensively discovered using high-throughput sequencing technology ([@b12-molce-39-5-367]). In the human genome, approximately 62% of the genome has been reproducibly transcribed ([@b12-molce-39-5-367]), of which approximately 30% corresponds to exonic and intronic regions of protein-coding genes, and the remainder mostly comprise long ncRNAs (lncRNAs) transcribed in intergenic regions or antisense strands ([@b20-molce-39-5-367]). Furthermore, protein-coding genes encode nine multiple isoforms on an average, very few of which lack coding potential and are regarded as noncoding isoforms ([@b42-molce-39-5-367]). date, tens of thousands of lncRNAs have been discovered in genomes and found to be involved in diverse biological functions such as regulating gene expression at the level of transcription, RNA processing, or translation; protecting genomes from transposons or viral DNAs; and guiding DNA synthesis, genome rearrangement, or genome editing ([@b10-molce-39-5-367]). The versatile functions of lncRNAs suggest that RNAs actively participate in diverse cellular processes and play a regulatory role in the expression of genetic information.

Ever-increasing evidence of the existence of bifunctional RNAs with coding and noncoding potential is being provided by current high-throughput RNA sequencing (RNA-seq) and ribosome footprinting followed by sequencing (Ribo-seq) ([@b2-molce-39-5-367]; [@b33-molce-39-5-367]). The existence of lncRNAs with small open reading frames (sORFs) ([@b2-molce-39-5-367]) and the intrinsic RNA function of protein-coding genes ([@b33-molce-39-5-367]) in species ranging from bacteria to mammals indicates that the bifunctional mode of RNAs has been evolutionarily conserved. Although mono-functional RNAs might be major players in current genomes, bifunctional RNAs seem to have significantly contributed to the complexity and robustness of gene expression regulation over time.

In this mini-review, we discuss three major types of bifunctional RNAs with both coding and noncoding potential: lncRNA with sORFs, coding mRNAs with noncoding functions, and noncoding isoforms of protein-coding genes. We then go on to summarize the functional categories of RNAs and their corresponding proteins or peptides.

BIFUNCTIONAL RNAs AND GENES
===========================

The first type of bifunctional RNA is lncRNA encoding small peptides. Recent studies have reported that a number of lncRNAs contain sORFs that extensively translate small peptides ([@b1-molce-39-5-367]; [@b3-molce-39-5-367]; [@b40-molce-39-5-367]; [@b46-molce-39-5-367]; [@b49-molce-39-5-367]). Analysis of sequence conservation ([@b1-molce-39-5-367]; [@b40-molce-39-5-367]) and high-throughput sequencing of ribosome-protected fragments (RPFs) ([@b3-molce-39-5-367]; [@b46-molce-39-5-367]; [@b49-molce-39-5-367]) have shown that small peptides from a considerable number of well-studied lncRNAs are actively synthesized ([@b2-molce-39-5-367]). Although the majority of functional proteins are composed of more than 100 amino acids, a considerable number of small peptides, comprising fewer than 100 amino acids, attributed to lncRNA, are also detectable from cells by ribosome footprinting and proteomics approaches. In addition, some sORFs but not their host lncRNAs are evolutionarily conserved in other genomes ([@b8-molce-39-5-367]; [@b28-molce-39-5-367]), indicating that they might play a functional role not related to the lncRNA functions in cells ([Fig. 1A](#f1-molce-39-5-367){ref-type="fig"}).

The second type of bifunctional RNA is coding mRNA having noncoding functions. So far, a dozen protein-coding mRNAs were revealed to have an intrinsic noncoding function, independent of the protein that they encode ([Fig. 1B](#f1-molce-39-5-367){ref-type="fig"}) ([@b30-molce-39-5-367]; [@b33-molce-39-5-367]). The intrinsic noncoding function of mRNAs is involved in core molecular processes such as transcriptional, posttranscriptional, and translational regulation, as well as protein scaffolding in *cis*- and *trans*-acting manners ([@b33-molce-39-5-367]).

The third type of bifunctional RNA is protein-coding RNA having either noncoding isoforms by alternative splicing or allele-specific transcripts with variants that destroy coding potential ([Figs. 1C and 1D](#f1-molce-39-5-367){ref-type="fig"}). The noncoding isoforms of protein-coding genes are often regarded as potential targets of nonsense-mediated mRNA decay (NMD); however, a considerable number appear to be sufficiently stable to have functional roles in cells ([@b43-molce-39-5-367]).

CODING POTENTIAL OF LncRNAs
===========================

LncRNA is defined as a long RNA molecule with no coding potential and no sequence similarity to protein-coding genes; however, several annotated lncRNAs appear to be highly associated with ribosomes ([Table 1](#t1-molce-39-5-367){ref-type="table"}), indicating that lncRNAs contain a coding region that translates a peptide. Of the lncRNAs manually curated in VEGA (<http://vega.sanger.ac.uk/>), a few display strong ribosomal association, indicating a high translation efficiency, in HeLa and mouse neutrophil cells ([Table 1](#t1-molce-39-5-367){ref-type="table"}). Intriguingly, the ribosome association is mostly restricted to sORFs, and this association rapidly decays at the location of ribosome release at the stop codon, estimated as the ribosome release score (RRS) ([@b18-molce-39-5-367]). For example, MALAT1 is highly expressed in the nucleus during cancer metastasis ([@b27-molce-39-5-367]) and has a putative sORF that can encode about 71 amino acids. In fact, the sORFs are strongly associated with ribosomes ([Fig. 2A](#f2-molce-39-5-367){ref-type="fig"}). Although *in vitro* translation experiments have failed to detect peptides from the putative sORF ([@b27-molce-39-5-367]), the strong ribosome association supports translation activity on the sORF. In addition, the movement of the 80S ribosome along the mRNA makes it possible to discern whether the sORF is actively translated. For example, RP11-21N3_1 lncRNA includes three putative sORFs strongly associated with ribosomes within a sORF with a subcodon positional bias of the 5′ termini of RPFs ([Fig. 2B](#f2-molce-39-5-367){ref-type="fig"}).

Another type of lncRNA, the miRNA host transcript, sometimes includes ribosome footprints on the RNA. For example, pri-miR171b in *Arabidopsis thaliana* is processed into miR171b and downregulates several solute carrier family members. Its primary transcript, called miPEP171b, has two sORFs, which encode five and twenty amino acids, respectively. These peptides specifically enhance the expression of miR171b, affecting lateral root development ([@b35-molce-39-5-367]).

CODING mRNAs WITH NONCODING FUNCTIONS
=====================================

Besides their protein-coding functions, mRNAs play functional roles as RNA, such as transcriptional and translational gene regulation and localization and scaffolding of proteins ([Table 2](#t2-molce-39-5-367){ref-type="table"}). In general, the intrinsic RNA function is mediated by either *cis*- or *trans*-acting elements on the RNA. In fact, the UTR of protein-coding mRNAs often harbors *cis*-acting factors that control their own stability, localization, and translation efficiency, which could be regarded as intrinsic functions of the mRNAs. For example, the 3′-UTRs of *DMPK*, *Oskar*, and *Sqt* include motifs recognized by RNA-binding proteins (RBPs), induce the formation of scaffolds of the RBPs during embryo development, and also encode DNA sequences of proteins composed of hundreds of amino acids ([@b25-molce-39-5-367]; [@b26-molce-39-5-367]; [@b37-molce-39-5-367]; [@b41-molce-39-5-367]).

In one sense, all protein-coding RNAs that have spatially separable functions of coding in coding sequences and noncoding in UTRs can be regarded as bifunctional RNAs. Intriguingly, the base compositions, structures, and functions of 3′-UTRs are similar to those of lncRNA genes ([@b44-molce-39-5-367]; [@b55-molce-39-5-367]), which indicates that UTRs might be traces (or fossils) of ancient regulatory RNAs in the view of the RNA world hypothesis. Of course, UTRs also mediate *trans*-gene regulation by competing with other endogenous RNAs. For example, the hairpin structure of the HIC 3′-UTR binds to and translationally activates P-TEFb by displacing 7SK RNA from the inhibitory complex ([@b58-molce-39-5-367]) ([Table 2](#t2-molce-39-5-367){ref-type="table"}). In addition, the UTRs interact with lncRNAs via imperfect base pairing based on Alu repeats, facilitating the formation of STAU1-binding sites ([@b16-molce-39-5-367]). This recruitment of STAU1 directs staufen-mediated mRNA decay (SMD), which controls the stability of the SMD target mRNAs ([Table 2](#t2-molce-39-5-367){ref-type="table"}). Notably, mRNAs with functional UTRs tend to have either sORFs or long UTRs, resembling lncRNAs with sORFs. For example, SgrS and ENOD40 mRNAs, which encode 43 and 27 amino acids, respectively, and yet have UTRs ∼100 nt and ∼600 nt in length, have noncoding functions of translational regulation and RNA stability ([@b19-molce-39-5-367]; [@b45-molce-39-5-367]; [@b52-molce-39-5-367]; [@b54-molce-39-5-367]) ([Table 2](#t2-molce-39-5-367){ref-type="table"}).

In some cases, the region responsible for the noncoding function, however, is barely separable from that required for its coding function. For example, RNAIII in *Staphylococcus aureus* encodes a delta-hemolysin comprising 26 amino acids, which induces the lysis of the host cell membranes. The RNA sequence includes the CDS and has an intrinsic function of regulating the stability and translation of virulence factors by base pairing ([@b53-molce-39-5-367]). Hence, the regions for coding and noncoding functions might not necessarily be distinct. VegT mRNA, which encodes a T-box transcription factor that patterns the mesendoderm of *Xenopus laevis,* plays a structural role in the organization of the cytoskeleton at the vegetal cortex ([@b31-molce-39-5-367]) ([Table 2](#t2-molce-39-5-367){ref-type="table"}). In addition, c-Myc, H2B, TP53, BCMAAS, and P23 have regulatory roles at the RNA level, but the regions for these functions are not clearly separable from the CDS regions ([Table 2](#t2-molce-39-5-367){ref-type="table"}). For spatially inseparable functional elements on RNA, it is difficult to pinpoint the functional roles of the elements by simply removing them. Rather, the functional role of these regions can be determined by introducing mutations in the element but with a minimal effect on the RNA sequence. Thus, at present, we classify these groups as potential bifunctional RNAs.

CODING AND NONCODING ISOFORMS OF PROTEIN-CODING GENES
=====================================================

A major isoform analysis of human transcriptomes has revealed that 15.26--20.64% of protein-coding genes in primary tissues express the major isoform that lacks an annotated CDS in GENCODE ([@b17-molce-39-5-367]). The major noncoding isoforms are recurrently expressed across tissues and cell lines, and their subcellular localization showed that they are enriched in the nucleus compared to other major coding isoforms. Although some of the noncoding isoforms enriched in the nucleus are likely to be retained introns, about half are processed transcripts, and their abundant levels indicate their functional roles in the primary tissues.

Processed noncoding transcripts are often generated by alternative splicing, which either introduces a premature stop codon (PTC) or disrupts the ORF ([@b17-molce-39-5-367]). Because transcripts with a PTC are easily damaged by the NMD pathway, processed noncoding transcripts with high expression levels are more likely to be non-NMD targets. Major noncoding isoforms mainly arise by alternative splicing or skipping the first or last exon, including the start or stop codons. For example, the *SRA* gene expresses coding isoforms produced by alternative start codons in the first exon and noncoding isoforms with a truncated or missed first exon ([@b11-molce-39-5-367]; [@b22-molce-39-5-367]; [@b34-molce-39-5-367]) ([Fig. 3](#f3-molce-39-5-367){ref-type="fig"}). The ratio of coding and noncoding isoforms is dynamically altered across different cell states or types. In fact, the fraction of noncoding isoforms increases during myogenic differentiation of primary human satellite cells, while the fraction decreases in myotonic dystrophy muscles ([@b22-molce-39-5-367]). The production of coding and noncoding isoforms of SRA is also observed in the mouse transcriptome, indicating that the dual function of coding and noncoding isoforms of SRA has been evolutionary conserved ([Fig. 3](#f3-molce-39-5-367){ref-type="fig"}).

An alternative source of noncoding transcripts of protein-coding genes could be allele-specific isoforms generated by heterozygous mutations that cause a loss of coding potential. In many cases, mutations in splice sites cause the truncation or retention of introns of transcripts, some of which are damaged by the NMD pathway ([@b48-molce-39-5-367]). In particular, these allele-specific isoforms are frequently discovered in cancer cells ([@b43-molce-39-5-367]), suggesting that the allelic imbalance of coding and noncoding transcripts of a protein-coding gene might be involved in the origin of cancer.

CONCLUSION
==========

The discovery of bifunctional genes raises several questions. How prevalent are genes with dual functions in genomes? How can we distinguish genuine coding RNA, ncRNA, and bifunctional RNA at the genome level? How do we examine the coding and noncoding functions of RNA? Finally, why do cells maintain the evolutionarily conserved dual functions of RNAs across species? To address these questions, genome-wide experimental and computational approaches to identify noncoding functions of protein-coding genes, detect putative sORFs in noncoding genes, and reconstruct noncoding isoforms in coding loci could be useful.

The coding potential of lncRNAs has been predicted computationally by comparing phylogenetic codon models across species, such as PhyloCSF ([@b38-molce-39-5-367]), or by experimentally detecting RNA regions associated with ribosomes ([@b18-molce-39-5-367]; [@b23-molce-39-5-367]). Despite the successful detection of putative sORFs in lncRNAs by the above methods, we need to further examine whether the peptides are productively generated, whether the peptides are stable in cells, and whether peptides from sORFs are functionally relevant.

A more prevalent source of bifunctional RNAs might be the noncoding isoforms of protein-coding genes. However, detecting the noncoding isoforms of protein-coding genes at the genome level is a challenging task. For this, the isoform-level analysis of ribosome footprinting might be helpful. In addition, to verify the function of the noncoding isoform, we can examine whether the function is maintained after removing the coding potential by introducing a frameshift mutation or nonsense mutation in the coding isoform.

Recently, many truncated proteins encoded from NMD targets and noncoding isoforms of protein-coding genes have been shown to have a stable form in NMD-deficient conditions, and to be involved in cancer development ([@b39-molce-39-5-367]; [@b56-molce-39-5-367]). This highlights the need to understand how distinct RNAs and proteins of bifunctional RNAs are pathologically relevant, which will in turn provide interesting biological insights with potential medical implications.
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![Four relevant scenarios of the generation of RNAs or genes with coding and noncoding functions. (A) lncRNAs with sORF. (B) Protein-coding mRNAs having non-coding functions. (C) Coding and noncoding isoforms of protein-coding genes by alternative splicing. (D) Allele-specific expression of coding and noncoding isoforms.](molce-39-5-367f1){#f1-molce-39-5-367}

![Ribosome-association signals on lncRNAs. (A) Strong RPF signals in a sORF of MALAT1 in HeLa cells and Malat1 in mouse neutrophils are shown. Yellow and green bars are EpsG protein and EpsG superfamily domains, respectively, detected from the NCBI Conserved Domain Database. (B) RPF signals in the lncRNA RP11-21N3_1 in HeLa cells.](molce-39-5-367f2){#f2-molce-39-5-367}

![An example of coding and noncoding isoforms from the human *SRA* gene with 5 exons, which is conserved in the mouse. The human *SRA* gene has 2 alternative start codons, whereas mouse SRA has 1 start codon and 2 stop codons. The gene produces both coding and noncoding isoforms, with the first intron retained in both human and mouse.](molce-39-5-367f3){#f3-molce-39-5-367}

###### 

lncRNAs with ribosome association

  Gene_ID         Species   Transcript (nt)   Putative ORF (nt)   TE[^\*^](#tfn1-molce-39-5-367){ref-type="table-fn"}   RPM[^\*\*^](#tfn2-molce-39-5-367){ref-type="table-fn"}   RRS[^\*\*\*^](#tfn3-molce-39-5-367){ref-type="table-fn"}
  --------------- --------- ----------------- ------------------- ----------------------------------------------------- -------------------------------------------------------- ----------------------------------------------------------
  RP5-875O13.1    Human     1548              78                  3.26                                                  122.76                                                   0.15
  CGAT1           Human     2131              210                 0.40                                                  45.71                                                    42.01
  SNHG8           Human     672               159                 1.62                                                  33.40                                                    52.62
  MALAT1          Human     8708              213                 0.01                                                  26.99                                                    1184.00
  CTD-2651B20.6   Human     308               72                  3.99                                                  21.92                                                    0.12
  GAS5            Human     1698              502                 0.10                                                  21.82                                                    170.13
  AC074183.4      Human     782               186                 5.44                                                  20.37                                                    78.00
  DANCR           Human     878               180                 0.23                                                  14.47                                                    116.37
  RP11-21N3.1     Human     918               300                 1.05                                                  12.51                                                    488.00
  RP11-220I1.1    Human     4375              192                 0.18                                                  11.58                                                    371.20
  RP11-354P17.9   Human     745               246                 0.93                                                  11.38                                                    69.54
  RPPH1           Human     638               108                 0.22                                                  10.34                                                    8.00
  RP23-381B19.2   Mouse     1428              279                 0.16                                                  25.85                                                    70.33
  Malat1          Mouse     6983              195                 0.01                                                  17.40                                                    1998.00
  RP23-73N16.7    Mouse     475               162                 0.81                                                  12.82                                                    0.42
  Gas5            Mouse     2556              177                 0.05                                                  8.44                                                     80.66

Translation Efficiency (TE)

Read per million mapped reads (RPM)

Ribosome Release Score (RRS)

###### 

List of bifunctional RNAs

  Bifunctional RNA                                Species                                                     RNA length   Peptide length        Coding function                                                                                                                                                                         Intrinsic function of RNA                                                                                                                                            RNA function category   References
  ----------------------------------------------- ----------------------------------------------------------- ------------ --------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------- ----------------------- ---------------------------------------------------------------------
  *RNAIII*                                        *Staphylococcus aureus*                                     514 nt       26 aa                 Delta-hemolysin that targets host cell membranes, causing lysis                                                                                                                         Regulation of stability and translation of virulence factors by base pairing                                                                                         Translation             [@b53-molce-39-5-367]
  *SgrS*                                          *Escherichia coli*                                          227 nt       43 aa                 SgrT, relieving glucose stress through a base pairing-independent mechanism                                                                                                             Negative regulation of the stability and translation of the major gulcose transporters ptsG and manXYZ via base pairing                                              Translation             [@b54-molce-39-5-367]
  *SR1*                                           *Bacillus subtilis*                                         117 nt       39 aa                 SR1P, stabilizing gapA operon RNA by binding to gapA protein but not RNA                                                                                                                Repression of transcription activator *ahrC* that regulates the arginine catabolic operons                                                                           Transcription           [@b15-molce-39-5-367]
  *ENOD40*                                        *Medicago truncatula, Oryza sativa, Arabidopsis thaliana*   ∼700 nt      I: 13 aa, II: 27 aa   Two ORFs, cell divisions at high frequency. Two peptides binds to sucrose synthase                                                                                                      MtRBP1 interacting with a secondary structure of interORF region, which is involved in translation regulation                                                        Translation             [@b19-molce-39-5-367]; [@b45-molce-39-5-367]; [@b52-molce-39-5-367]
  *VegT*                                          *Xenopus laevis*                                            2703 nt      455 aa                VegT codes for a T-box TF that patterns the mesendoderm                                                                                                                                 VegT mRNA and ncRNA, Xlsirts play structural roles in the organization of the cytoskeleton at the vegetal cortex                                                     Scaffolding             [@b31-molce-39-5-367]
  *Oskar*                                         *Drosophila melanogaster*                                   2869 nt      606 aa                Involved in late oogenesis function                                                                                                                                                     Oskar 3′UTR, scaffolding RBPs, regulating early oogenesis function                                                                                                   Scaffolding             [@b26-molce-39-5-367]
  *Sqt*                                           *Danio rerio*                                               1480 nt      392 aa                Nodal signaling in mesendoderm induction and patterning, and specification of the neural tube                                                                                           Sqt 3′UTR, scaffolding RBPs, initiation of dorsal axis specification                                                                                                 Scaffolding             [@b37-molce-39-5-367]
  *c-Myc* (potential)*, Brca1, Klf4, and Dnmt1*   *Homo sapiens, Mus musculus*                                \-           \-                    Oncogenic and tumor suppressor function                                                                                                                                                 Cis-trascriptional regulation by binding to PRC2 and EZH2, polycomb repressive complex                                                                               Transcription           [@b30-molce-39-5-367]; [@b60-molce-39-5-367]
  *DMPK*                                          *Homo sapiens*                                              3243 nt      639 aa                Delayed onset of mild myotonic dystrophy symptoms                                                                                                                                       DMPK 3′UTR, CUG repeat forms hairpin structure that sequesters developmentally regulated splicing factors like MBNL, leading to severe myotonic dystrophy symptoms   Scaffolding             [@b25-molce-39-5-367]; [@b41-molce-39-5-367]
  *TP53* (potential)                              *Homo sapiens*                                              2591 nt      393 aa                Transcription factor in response to DNA-damage, hypoxia, nutrient deprivation, and telomere damage, which can lead to cancer. Initiating a program of cell cycle arrest and apoptosis   Enhance p53 translation and stabilization by interacting with Mdm2                                                                                                   Translation             [@b9-molce-39-5-367]
  *H2B*                                           *Homo sapiens*                                              431 nt       126 aa                Replication-dependent histone gene                                                                                                                                                      Nucleation of nuclear bodies (histone locus bodies, nuclear speckles, paraspeckles, and nuclear stress bodies)                                                       Scaffolding             [@b51-molce-39-5-367]
  *HIC*                                           *Homo sapiens*                                              5312 nt      152 aa                Involved in transcriptional regulation of viral genome expression                                                                                                                       HIC 3′UTR hairpin structure, binds to and activates P-TEFb by displacing 7SK RNA from inhibitory complex                                                             Translation             [@b58-molce-39-5-367]
  *BCMA-AS*                                       *Homo sapiens*                                              \>345 nt     115 aa                p12, ?                                                                                                                                                                                  BCMA translation repression                                                                                                                                          Translation             [@b21-molce-39-5-367]
  *P23/TCTP*                                      *Homo sapiens*                                              4814 nt      197 aa                Control of homeostasis                                                                                                                                                                  Inhibits translation by interacting with the RNA binding domain of PKR                                                                                               Translation             [@b6-molce-39-5-367]
  SMD targets                                     *Homo sapiens*                                              varying      varying               varying                                                                                                                                                                                 Stability control of interacting SMD targets and lncRNA via Alu repeats                                                                                              Post-transcription      [@b16-molce-39-5-367]
  SRA                                             *Homo sapiens*                                              2015 nt      236 or 208 aa         RNA binding and related to breast cancer                                                                                                                                                Nuclear receptor coactivator                                                                                                                                         Coactivator             [@b11-molce-39-5-367]; [@b22-molce-39-5-367]; [@b34-molce-39-5-367]
